Pages that link to "Q59632258"
Jump to navigation
Jump to search
The following pages link to IL-27 mediates the response to IFN-β therapy in multiple sclerosis patients by inhibiting Th17 cells (Q59632258):
Displaying 50 items.
- Th17 cells in autoimmune and infectious diseases (Q21284677) (← links)
- Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications (Q26768649) (← links)
- Regulatory T cells in autoimmune neuroinflammation (Q26825063) (← links)
- Interleukin-27: balancing protective and pathological immunity (Q26830400) (← links)
- Multiple sclerosis: the role of cytokines in pathogenesis and in therapies (Q27011014) (← links)
- Role of the immunogenic and tolerogenic subsets of dendritic cells in multiple sclerosis (Q28082878) (← links)
- No quiet surrender: molecular guardians in multiple sclerosis brain (Q28084633) (← links)
- Multiple Sclerosis and T Lymphocytes: An Entangled Story (Q28086853) (← links)
- Circulating concentrations of interleukin (IL)-17 in patients with multiple sclerosis: Evaluation of the effects of gender, treatment, disease patterns and IL-23 receptor gene polymorphisms (Q33896806) (← links)
- IL-27-induced modulation of autoimmunity and its therapeutic potential (Q34488727) (← links)
- Endogenous interferon-β-inducible gene expression and interferon-β-treatment are associated with reduced T cell responses to myelin basic protein in multiple sclerosis. (Q35146806) (← links)
- Interferon-β suppresses murine Th1 cell function in the absence of antigen-presenting cells (Q35461764) (← links)
- Induction of regulatory Tr1 cells and inhibition of T(H)17 cells by IL-27. (Q35592657) (← links)
- Current status of the immunomodulation and immunomediated therapeutic strategies for multiple sclerosis (Q35606563) (← links)
- Interferon regulatory factor-7 modulates experimental autoimmune encephalomyelitis in mice. (Q35677443) (← links)
- Anti-inflammatory mechanisms of IFN-γ studied in experimental autoimmune encephalomyelitis reveal neutrophils as a potential target in multiple sclerosis (Q35964276) (← links)
- Endogenous, or therapeutically induced, type I interferon responses differentially modulate Th1/Th17-mediated autoimmunity in the CNS. (Q36001691) (← links)
- Differential effects of IFN-β on IL-12, IL-23, and IL-10 expression in TLR-stimulated dendritic cells (Q36143414) (← links)
- Immunologic and MRI markers of the therapeutic effect of IFN-β-1a in relapsing-remitting MS. (Q36280862) (← links)
- Protein expression profiling of inflammatory mediators in human temporal lobe epilepsy reveals co-activation of multiple chemokines and cytokines (Q36372950) (← links)
- Interferon-β therapy against EAE is effective only when development of the disease depends on the NLRP3 inflammasome (Q36431053) (← links)
- Gene therapy using IL-27 ameliorates Sjögren's syndrome-like autoimmune exocrinopathy (Q36633351) (← links)
- Role of toll-like receptors in multiple sclerosis (Q37021687) (← links)
- Increased CD8+ T cell responses to apoptotic T cell-associated antigens in multiple sclerosis (Q37071787) (← links)
- Independent and interdependent immunoregulatory effects of IL-27, IFN-β, and IL-10 in the suppression of human Th17 cells and murine experimental autoimmune encephalomyelitis. (Q37264717) (← links)
- Modulation of inflammation by interleukin-27. (Q37309924) (← links)
- TH17 cytokines in autoimmune neuro-inflammation (Q37930157) (← links)
- IL-17 producing T cells in mouse models of multiple sclerosis and rheumatoid arthritis (Q37974565) (← links)
- Type I IFN-mediated regulation of IL-1 production in inflammatory disorders. (Q38004932) (← links)
- Cytokine control of inflammation and repair in the pathology of multiple sclerosis. (Q38067389) (← links)
- Innate immune responses in the CNS: role of toll-like receptors, mechanisms, and therapeutic opportunities in multiple sclerosis (Q38118170) (← links)
- Interleukin-12 family cytokines and sarcoidosis (Q38266881) (← links)
- Interferon-β regulates dendritic cell activation and migration in experimental autoimmune encephalomyelitis (Q38710997) (← links)
- Dendritic cells as gatekeepers of tolerance. (Q38908238) (← links)
- Type two innate lymphoid cells: the Janus cells in health and disease. (Q39402904) (← links)
- Dual Inhibition of TNFR1 and IFNAR1 in Imiquimod-Induced Psoriasiform Skin Inflammation in Mice (Q40695075) (← links)
- Type I interferon restricts type 2 immunopathology through the regulation of group 2 innate lymphoid cells (Q40899547) (← links)
- Increased interleukin-27 cytokine expression in the central nervous system of multiple sclerosis patients (Q41112107) (← links)
- New Approaches to the Immunotherapy of Type 1 Diabetes Mellitus Using Interleukin-27. (Q42012784) (← links)
- Immunoregulatory function of IL-27 and TGF-β1 in cardiac allograft transplantation. (Q42325261) (← links)
- Casein kinase 2 is a critical determinant of the balance of Th17 and Treg cell differentiation (Q42370428) (← links)
- Type I interferon potentiates T-cell receptor mediated induction of IL-10-producing CD4⁺ T cells. (Q45720900) (← links)
- Toll-like receptor 3 activation modulates hippocampal network excitability, via glial production of interferon-β. (Q48098109) (← links)
- Interferon-β regulates the production of IL-10 by toll-like receptor-activated microglia (Q48272369) (← links)
- Protective effect of tanreqing injection on axon myelin damage in the brain of mouse model for experimental autoimmune encephalomyelitis. (Q48449365) (← links)
- Effector T Cells in Multiple Sclerosis (Q49874524) (← links)
- Cytokine Profile in Patients with Progressive Multiple Sclerosis and Its Association with Disease Progression and Disability. (Q52143402) (← links)
- Production of IL-27 in multiple sclerosis lesions by astrocytes and myeloid cells: Modulation of local immune responses. (Q52145132) (← links)
- Mechanisms of Tolerance Induction by Dendritic Cells In Vivo. (Q54256455) (← links)
- Characterization of the interaction between astrocytes and encephalitogenic lymphocytes during the development of experimental autoimmune encephalitomyelitis (EAE) in mice. (Q54285111) (← links)